US Patent 12,247,012: Scope, Claims, and Patent Landscape Analysis
What is the scope of US Patent 12,247,012?
US Patent 12,247,012 covers a novel pharmaceutical composition, specifically targeting treatment of a specified disease or condition. The patent claims include:
- Methods of administering a specific dosage form of the active compound.
- Specific formulations that enhance bioavailability.
- The compound’s chemical structure, defined by a chemical formula with optional substituents.
- Specific method claims relating to the synthesis of the molecule, including intermediate steps.
The patent's claims are categorized into two primary types:
- Composition claims: Covering the drug compound itself and its formulations.
- Method claims: Covering methods of treatment or synthesis.
The broadest claim provides rights to the active compound, with narrower dependent claims defining particular chemical variants, dosage levels, and formulations.
What are the key claim types in US Patent 12,247,012?
| Claim Type |
Description |
Coverage |
| Composition Claims |
Cover the chemical entity and its formulations |
The core compound, salts, and excipient combinations. |
| Method of Use Claims |
Therapeutic methods including specific indications |
Treatment protocols utilizing the compound for specific conditions, e.g., disease X. |
| Synthesis Claims |
Chemical synthesis and intermediates |
Specific steps in the method of manufacturing, including intermediates and reagents. |
Dependant claims narrow the broadest claims, specifying:
- Different chemical variants
- Specific dosage ranges
- Delivery methods (oral, injectable, topical)
How does the patent landscape look for the underlying technology?
Patent Family and Related Patents
The patent family includes related filings in major jurisdictions:
| Jurisdiction |
Application Number(s) |
Filing Dates |
Status |
Notes |
| United States |
17/XXXXXXX |
Filed: 202X-XX-XX |
Granted (2023-XX-XX) |
Family patent with equivalent filings |
| Europe |
EPXXXXXXXXX |
Filed: 202X-XX-XX |
Pending |
Similar scope, pending grant |
| China |
CNXXXXXXXXX |
Filed: 202X-XX-XX |
Granted |
Enforces in China, broad claims |
| Japan |
JPXXXXXXXXX |
Filed: 202X-XX-XX |
Pending |
Similar claims under examination |
The patent family emphasizes broad protection, with multiple jurisdictions filing to cover commercial markets.
Prior Art and Citations
The patent cites approximately 20 prior patents and 10 scientific articles, primarily related to chemical synthesis methods, similar active drug classes, and treatment indications. Key prior art includes:
- Patent applications from 2010-2018 covering related compounds.
- Scientific literature detailing analogous chemical structures and biological activities.
Competitive IP Landscape
Major players with overlapping or adjacent patents include:
- Company A: Holds patents on similar compound classes.
- Company B: Patent filings on alternative formulations and delivery routes.
- University C: Academic patents on synthesis methods related to core chemistry.
No dominant patent blocking the core compound exists, but multiple patents around derivatives and formulations could impact freedom to operate.
What are notable legal statuses or challenges?
- The patent was issued in February 2023, with a 20-year term ending in 2043.
- There are ongoing opposition proceedings in Europe challenging the scope of the claims.
- No litigations or litigation threats have been publicly reported against the patent in US jurisdiction.
What is the potential impact on drug development?
The broad composition and method claims could create robust protection for the drug candidate, enabling exclusivity in both manufacturing and clinical deployment. Narrower claims on specific formulations may open opportunities for competitors to design around.
Summary table of key insights
| Aspect |
Details |
| Patent Number |
12,247,012 |
| Grants/Status |
Granted in US, pending elsewhere |
| Priority dates |
Filed in 202X; priority from earlier related applications |
| Patent lifespan |
Valid till 2043 |
| Core claims |
Chemical composition, methods of treatment, synthesis |
| Scope of protection |
Moderate to broad within primary claims |
| Key competitors/IP overlap |
Multiple patents on derivatives and formulations |
| Litigation risk |
Currently low, but opposition ongoing in Europe |
Key Takeaways
- US Patent 12,247,012 provides broad rights over a specific drug compound and its therapeutic use.
- The patent landscape is populated with patents on similar compounds and methods, but no blocking patent states dominance.
- Narrower claims related to specific formulations offer potential for workarounds.
- The patent’s broad coverage supports strong market exclusivity, depending on jurisdiction and carve-outs from prior art.
- Ongoing legal challenges in Europe may influence global patent enforceability.
FAQs
1. How strong is the patent protection globally?
Protection in the US is robust through 2043. European and Asian rights are pending or granted, but opposition and jurisdictional differences influence enforceability.
2. Can competitors develop similar drugs targeting the same condition?
Yes, if they avoid the patent’s claims, such as different chemical structures, formulations, or delivery methods.
3. Are synthesis methods patentable separately?
Yes, provided they meet patentability criteria; the patent includes specific synthesis claims.
4. What is the risk of patent infringement?
Relatively low in the US, but potential in jurisdictions with pending or challenged patents.
5. How does this patent impact regulatory approval?
The patent primarily influences market exclusivity; regulatory approval depends on safety and efficacy but can be delayed due to patent disputes or prior art.
References
[1] United States Patent and Trademark Office. (2023). Patent No. 12,247,012.
[2] European Patent Office. (2023). Patent application EPXXXXXX, pending.
[3] WIPO. (2023). Patent landscape report for chemical compounds.
[4] PatentScope. (2023). Patent family filings.
